Case report: Levodopa challenge test is i... - Cure Parkinson's

Cure Parkinson's

26,571 members27,876 posts

Case report: Levodopa challenge test is important in identifying dopamine-induced freezing of gait in patient with Parkinson’s disease

Farooqji profile image
2 Replies

female PD patient complicated with dopamine-induced FOG, which was identified during levodopa challenge test. Her symptoms were alleviated after adjusting the medication.

frontiersin.org/journals/hu...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Juliegrace profile image
Juliegrace

The levodopa induced freezing of gait (FOG) is definitely one of my most challenging and unpleasant symptoms. Sadly, my PD is not benign and I have always suffered from dyskinesia. So, adjusting my meds is not an option for me, which is why I’m having DBS which I’m hoping will allow me to reduce my meds.

cjCardio53 profile image
cjCardio53 in reply toJuliegrace

Hi, freezing is my biggest issue too. I have tried alot of diffrent things: med adjustments, excercise, cryothreapy, infared threapy, e stim, nothing seeems to help. My MD SAID DBS doesn't help with these symptoms...I also purchased: electric scooter, w/c, crutches, u-step, rollator walker, again nothing helps me.

Not what you're looking for?

You may also like...

A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

Can the technical people explain the significance of this article:...
pvw2 profile image

Levodopa-Induced Euphoria and Addictions in Parkinson’s. It's of concern for people with neuropsychiatric fluctuations between ON and OFF.

I'm referencing a 2017 research article. Some people have more significant neuropsychiatric...
ElliotGreen profile image

Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease

Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s...

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...